07.06.2019
VALBIOTIS to present novel data about TOTUM-63 and metabolic diseases prevention at the 2019 scientific sessions of the American Diabetes Association
Download
28.05.2019
VALBIOTIS succeeds in the industrial production of VALEDIA®, a major scientific innovation for prediabetic people, in collaboration with the Pierre Fabre group
Download
14.05.2019
VALBIOTIS will present the results of the international Phase IIA clinical study of VALEDIA® before 31 July 2019
Download
19.03.2019
VALBIOTIS strengthens its Supervisory Board with the appointment of Agnès TIXIER
Download
11.03.2019
VALBIOTIS reports exclusive data on the prediabetes market: a considerable potential for VALEDIA®
Download
